Kevin Caliendo
Stock Analyst at UBS
(4.00)
# 584
Out of 5,111 analysts
203
Total ratings
64.42%
Success rate
7.01%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintains: Buy | $96 → $97 | $79.69 | +21.72% | 11 | Dec 10, 2025 | |
| SOLV Solventum | Maintains: Neutral | $77 → $79 | $81.89 | -3.53% | 2 | Nov 10, 2025 | |
| LFST LifeStance Health Group | Maintains: Buy | $9 → $10 | $6.92 | +44.51% | 6 | Nov 7, 2025 | |
| COR Cencora | Maintains: Buy | $380 → $415 | $350.32 | +18.46% | 4 | Nov 7, 2025 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $4.25 → $4 | $2.71 | +47.60% | 7 | Nov 6, 2025 | |
| MCK McKesson | Maintains: Buy | $920 → $980 | $823.01 | +19.08% | 17 | Nov 6, 2025 | |
| OMI Owens & Minor | Downgrades: Neutral | $7 → $4 | $3.01 | +32.89% | 7 | Nov 3, 2025 | |
| CAH Cardinal Health | Maintains: Buy | $185 → $220 | $199.96 | +10.02% | 18 | Oct 31, 2025 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $17 → $18 | $20.11 | -10.49% | 8 | Oct 31, 2025 | |
| UNH UnitedHealth Group | Maintains: Buy | $378 → $430 | $341.10 | +26.06% | 13 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $325 → $320 | $263.33 | +21.52% | 7 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $23 | $11.40 | +101.75% | 12 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $170 | $166.50 | +2.10% | 5 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $190 | $184.11 | +3.20% | 16 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $160 → $155 | $162.73 | -4.75% | 19 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $75 → $70 | $77.39 | -9.55% | 6 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $18 → $22 | $22.06 | -0.27% | 4 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $15 | $4.12 | +264.08% | 3 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $9 | $4.70 | +91.49% | 3 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $410 → $390 | $277.15 | +40.72% | 11 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $380 → $250 | $274.74 | -9.00% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $40.45 | +95.30% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $360.67 | +59.43% | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $214.17 | -15.95% | 7 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $7.34 | +880.93% | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $30.13 | -63.49% | 4 | May 4, 2021 |
CVS Health
Dec 10, 2025
Maintains: Buy
Price Target: $96 → $97
Current: $79.69
Upside: +21.72%
Solventum
Nov 10, 2025
Maintains: Neutral
Price Target: $77 → $79
Current: $81.89
Upside: -3.53%
LifeStance Health Group
Nov 7, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $6.92
Upside: +44.51%
Cencora
Nov 7, 2025
Maintains: Buy
Price Target: $380 → $415
Current: $350.32
Upside: +18.46%
GoodRx Holdings
Nov 6, 2025
Maintains: Neutral
Price Target: $4.25 → $4
Current: $2.71
Upside: +47.60%
McKesson
Nov 6, 2025
Maintains: Buy
Price Target: $920 → $980
Current: $823.01
Upside: +19.08%
Owens & Minor
Nov 3, 2025
Downgrades: Neutral
Price Target: $7 → $4
Current: $3.01
Upside: +32.89%
Cardinal Health
Oct 31, 2025
Maintains: Buy
Price Target: $185 → $220
Current: $199.96
Upside: +10.02%
Alignment Healthcare
Oct 31, 2025
Maintains: Neutral
Price Target: $17 → $18
Current: $20.11
Upside: -10.49%
UnitedHealth Group
Oct 29, 2025
Maintains: Buy
Price Target: $378 → $430
Current: $341.10
Upside: +26.06%
Oct 29, 2025
Maintains: Buy
Price Target: $325 → $320
Current: $263.33
Upside: +21.52%
Oct 28, 2025
Maintains: Buy
Price Target: $24 → $23
Current: $11.40
Upside: +101.75%
Oct 24, 2025
Maintains: Neutral
Price Target: $180 → $170
Current: $166.50
Upside: +2.10%
Oct 17, 2025
Maintains: Neutral
Price Target: $180 → $190
Current: $184.11
Upside: +3.20%
Oct 16, 2025
Maintains: Neutral
Price Target: $160 → $155
Current: $162.73
Upside: -4.75%
Aug 6, 2025
Maintains: Neutral
Price Target: $75 → $70
Current: $77.39
Upside: -9.55%
Jul 29, 2025
Maintains: Neutral
Price Target: $18 → $22
Current: $22.06
Upside: -0.27%
May 9, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $4.12
Upside: +264.08%
May 8, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $4.70
Upside: +91.49%
Feb 3, 2025
Maintains: Buy
Price Target: $410 → $390
Current: $277.15
Upside: +40.72%
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $274.74
Upside: -9.00%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $40.45
Upside: +95.30%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $360.67
Upside: +59.43%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $214.17
Upside: -15.95%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $7.34
Upside: +880.93%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $30.13
Upside: -63.49%